A Multi-center, Randomized, Double-blind Phase III Clinical Trial to Assess and Compare to the Efficacy and Safety of Lafutidine, Famotidine and Omeprazole-referenced in Korean Erosive Esophagitis Patients

Clinical trial NCT01499368 · COMPLETED

Trial details

NCT number: NCT01499368
Sponsor: Boryung Pharmaceutical Co., Ltd
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Erosive Esophagitis

Start date: 2011-11-01
Primary completion: 2012-11-01
Enrollment: 495

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.